Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India
Jesil Mathew Aranjani, Atulya Manuel, Habeeb Ibrahim Abdul Razack, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009921-e0009921
Open Access | Times Cited: 106
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Valliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. e240-e253
Open Access | Times Cited: 67
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 46
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases
Matthias Egger, Martin Hoenigl, George R. Thompson, et al.
Mycoses (2022) Vol. 65, Iss. 6, pp. 599-612
Open Access | Times Cited: 47
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 4, pp. 466-479
Open Access | Times Cited: 40
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review
Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 39
What Is New in Pulmonary Mucormycosis?
François Danion, Anne Coste, Coralie Le Hyaric, et al.
Journal of Fungi (2023) Vol. 9, Iss. 3, pp. 307-307
Open Access | Times Cited: 27
Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme
Laura Gouzien, Didier Che, Sophie Cassaing, et al.
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101010-101010
Open Access | Times Cited: 9
Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study
Valliappan Muthu, Mohan Kumar, Raees A. Paul, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1291-1297
Open Access | Times Cited: 41
Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, et al.
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 35
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India – a multi-centre study
Manisha Biswal, Parikshaa Gupta, Rimjhim Kanaujia, et al.
Journal of Hospital Infection (2022) Vol. 122, pp. 173-179
Open Access | Times Cited: 34
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
Bishan Das Radotra, Sundaram Challa
Current Fungal Infection Reports (2022) Vol. 16, Iss. 4, pp. 206-220
Open Access | Times Cited: 31
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Madhavan Yasasve, Kadambari Vijay Sai, Dilip Kumar Shanmugam, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3620-3620
Open Access | Times Cited: 28
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections
Jeffrey D. Jenks, P. Lewis White, Sarah Kidd, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 12, pp. 1135-1152
Closed Access | Times Cited: 18
COVID-19-associated mucormycosis in India: Why such an outbreak?
Grégoire Pasquier
Journal de Mycologie Médicale (2023) Vol. 33, Iss. 3, pp. 101393-101393
Open Access | Times Cited: 17
Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 3, pp. 368-374
Closed Access | Times Cited: 17
Fungal positivity seen in tertiary care hospital during COVID-19 pandemic
Ravinder Kaur, Deepti Rawat, Ashish William, et al.
Access Microbiology (2025) Vol. 7, Iss. 1
Open Access
Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds
C. Orla Morrissey
Journal of Antimicrobial Chemotherapy (2025) Vol. 80, Iss. Supplement_1, pp. i17-i39
Open Access
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
Himanshu Pruthi, Valliappan Muthu, Harish Bhujade, et al.
Mycopathologia (2021) Vol. 187, Iss. 1, pp. 31-37
Open Access | Times Cited: 36
Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study
Mohan Kumar, Prashant Sharma, Shivaprakash M. Rudramurthy, et al.
Mycoses (2021) Vol. 65, Iss. 1, pp. 120-127
Open Access | Times Cited: 34
In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis
Omkar Pokharkar, Hariharan Lakshmanan, Grigory V. Zyryanov, et al.
Marine Drugs (2022) Vol. 20, Iss. 3, pp. 215-215
Open Access | Times Cited: 26
COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
Beeke Tappe, Chris D. Lauruschkat, Lea Strobel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans
Genna E. Davies, Christopher R. Thornton
Journal of Fungi (2022) Vol. 8, Iss. 7, pp. 756-756
Open Access | Times Cited: 22
COVID-19-associated Mucormycosis: A clinico-epidemiological study
Jaya Chakravarty, Munesh Kumar Gupta, Ragini Tilak, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 9, pp. 108284-108284
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top